The board meeting centered on a presentation by the President of the Board of Dental Examiners regarding wellness programs. Discussions focused on the board's protocol for self-reporting substance abuse cases and the potential for early intervention to support licensees. The board examined the effectiveness of current policies and the need to improve awareness of resources for licensed professionals, specifically regarding wellness matters unrelated to substance abuse and potential procedural adjustments to encourage self-reporting.
Sep 16, 2026
Enterprise
Get verified public-sector contacts at scale
Find verified emails, direct dials, role context, job-change updates, and organization signals across every public-sector account you sell to.
The board reviewed reports from the Wellness Committee, the Treasury, and the Chief Investigator. Key discussion topics included updates on the monitoring of pharmacy professionals, an overview of fiscal year financial performance with projections for future budget requirements, and statistics regarding compliance inspections and complaint investigations. Additionally, the board acknowledged recent staff participation in an inter-agency narcotics conference and reported on the status of pharmacy burglaries in the state.
Aug 19, 2026·Board meeting
Board of Pharmacy Board Meeting
The board reviewed requests for pharmacy services permits, including a presentation by Tanner Health regarding their proposal to transition remote after-hours order verification services in-house. This prompted a technical discussion regarding regulatory requirements and appropriate permitting classifications for out-of-state institutional pharmacies. Additionally, the board heard a presentation from True North RX concerning their service model, which focuses on patient medication consultation and care coordination, explicitly excluding dispensing, prescribing, or diagnostic services. The board subsequently approved the pharmacy services permit for True North RX.
Jul 15, 2026·Board meeting
Board Of Pharmacy Board Meeting
The board meeting covered several regulatory and administrative topics. Key discussions included the current FDA stance on compounding peptides, with a focus on which peptides are permissible for compounding and the requirement for pharmacists to adhere to United States Pharmacopeia (USP) standards as mandated by federal law. The board also received a treasurer's report detailing the fiscal year's revenue and operating expenses, as well as a wellness committee report regarding monitoring of health professionals.
